Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
eMed
Miami, Florida, United Statesemed.com ↗
- Ownership
- Private
- Employees
- ~1150
- Development stage
- Other
01
Overview
eMed operates a commercial telehealth and at-home diagnostics platform providing at-home blood testing, remote drug screening, and GLP-1/GIP-based chronic care and weight management programs, with reported average weight loss of about 21 lbs in 6 months in its GLP-1 program.[1][5][9]
- Therapeutic areas
- EndocrinologyMetabolic Disorders
- Modalities
- DeviceNon-pharmacological therapySmall molecule
- Industry
- Non-Academic Healthcare
Beyond the preview
Go deeper on eMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on eMed.